Search Results 1241-1250 of 17625 for treatment resistant depression
The purpose of this two-stage Phase 2 study is to assess the clinical response (Complete Remission) to FLAM compared to AM treatment in refractory or relapsed ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is a ...
Beck Depression Inventory (Short) Score ≥ 12 and/or uncontrolled depression after pre-enrollment psychological and medical assessment. Patient score > 2 in ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple ...
Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...
... Treat Subjects with Relapsed or Refractory Multiple Myeloma and ... therapy, but this study will administer treatment in approximately 3 weeks.
... treatments and personalize treatment options. Harnessing the ... Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some ...
In addition, secondary endpoints also include differences in symptoms of anxiety and depression. Participation eligibility. Participant eligibility includes age ...
青春期的激素变化可能会增大一些女孩患抑郁症的风险。然而，与青春期激素波动有关的暂时性情绪波动是正常的，这些变化本身不会导致抑郁症。
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.